secwatch.observer — SEC 8-K summary
======================================

Issuer:     CRYO CELL INTERNATIONAL INC (CCEL)
CIK:        0000862692
Form:       8-K
Filed at:   2022-01-25T23:59:59+00:00
Accession:  0000950170-22-000481
Event type: regulatory
Sentiment:  negative
Materiality: 0.50
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Cryo-Cell receives Nasdaq notice for audit committee non-compliance; cure period until Sept 2022
--------------------------------------------------------------------------------

- Nasdaq notified that audit committee has only 2 independent members, needs 3 per Rule 5605.
- Cure period: earlier of next annual meeting or September 20, 2022 (or March 21, 2022 if meeting before that).
- Company must submit documentation evidencing compliance by the cure deadline.
- Cryo-Cell states it is working diligently to regain compliance within the cure period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/862692/000095017022000481/0000950170-22-000481-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/862692/000095017022000481/ccel-20220119.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-000481

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer